Overcoming Barriers to Warfarin Patient Self-management Implementation in the US Healthcare System
In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.
• At least 18 years of age treated with warfarin for any indication for at least 9 months prior to enrollment
• Demonstrate the willingness and ability to test their own INR using a home INR monitoring device or have same-day access to clinic-derived INR results (e.g., via electronic medical record secure messaging)
• Willing to make independent decisions about warfarin dosing based on INR results
• Able to perform INR tests at least every 2 weeks
• Currently have and willing to maintain internet access for the duration of the study in order to complete online data collection forms
• Have an anticipated duration of warfarin therapy of at least 6 months